(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 10.72% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 7.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.43%.
Cognex's revenue in 2026 is $971,705,000.On average, 25 Wall Street analysts forecast CGNX's revenue for 2026 to be $179,329,912,430, with the lowest CGNX revenue forecast at $168,603,637,294, and the highest CGNX revenue forecast at $193,408,148,546. On average, 20 Wall Street analysts forecast CGNX's revenue for 2027 to be $195,922,119,281, with the lowest CGNX revenue forecast at $180,503,098,773, and the highest CGNX revenue forecast at $222,235,012,974.
In 2028, CGNX is forecast to generate $229,944,523,228 in revenue, with the lowest revenue forecast at $213,519,914,426 and the highest revenue forecast at $244,693,151,540.